Add like
Add dislike
Add to saved papers

Laparoscopic cholecystectomy in patients with porcelain gallbladder based on the preoperative ultrasound findings.

BACKGROUND/AIMS: Porcelain gallbladder is considered a relative contraindication to laparoscopic cholecystectomy, because of a high incidence of gallbladder cancer or gastrointestinal cancer. We examined the management of laparoscopic cholecystectomy in patients with porcelain gallbladder.

METHODOLOGY: 1,608 patients underwent cholecystectomy and 13 (0.81%) patients had porcelain gallbladder. All patients underwent preoperative spiral computed tomography after intravenous infusion cholangiography and intraoperative cholangiography. Patients with porcelain gallbladder were classified as Type I to III according to preoperative ultrasound findings. The Type I porcelain gallbladder was indicated for laparoscopic cholecystectomy and Type II porcelain gallbladder was selected for open cholecystectomy.

RESULTS: The laparoscopic cholecystectomy was completed in 10 patients with Type I porcelain gallbladder and the microscopie diagnosis demonstrated no cancer in the calcified wall of the gallbladder. In one patient with a non-transected injury to the right hepatic duct, a T-drainage tube was inserted at the site of the injury using the laparoscopic technique. Three patients with Type II porcelain gallbladder underwent open cholecystectomy and one patient had gallbladder cancer, therefore additional hepatectomy and lymphadenectomy was performed.

CONCLUSIONS: We conclude that patients with a Type I porcelain gallbladder should be considered for laparoscopic cholecystectomy using a preoperative selection based on the ultrasound findings.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app